Role of protein’s and future treatment options for Alzheimer’s Disease

Role of protein’s and future treatment options for Alzheimer’s Disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografiset tiedot
Päätekijä:	Islam, Md. Irfath
Muut tekijät:	Haque, Md. Aminul
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2023
Aiheet:	Alzheimer‘s disease APP Amyloid-beta Tau hyperphosphorylation Synaptic dysfunction Treatment Alzheimer's diseases > Treatment.
Linkit:	http://hdl.handle.net/10361/18134

Samankaltaisia teoksia

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
Tekijä: Aana, Afsara Sumon
Julkaistu: (2021)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
Tekijä: Halim, Rabea
Julkaistu: (2022)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
Tekijä: Saha, Bithi Rani
Julkaistu: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
Tekijä: Aziz, Farhin
Julkaistu: (2019)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Tekijä: Alim, Abdul
Julkaistu: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
Tekijä: Afra, Sumaiya
Julkaistu: (2022)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
Tekijä: Tamanna, Mst. Taskia
Julkaistu: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
Tekijä: Hassan, Md. Muhtaz
Julkaistu: (2020)

Emerging therapies of Alzheimer’s disease: a comprehensive review
Tekijä: Tasin, Md Abtahi
Julkaistu: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
Tekijä: Chowdhury, Sariya Uzrat
Julkaistu: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Tekijä: Tabassum, Nadira
Julkaistu: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
Tekijä: Shehab, Habibul Mohsin
Julkaistu: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Tekijä: Ishrat, Nowshin
Julkaistu: (2024)

Alzheimer's disease and marriage : an intimate account /
Tekijä: Wright, Lore K.
Julkaistu: (1993)

Marine compounds in the treatment of Alzheimer’s disease
Tekijä: Parveen, Sanjana
Julkaistu: (2022)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Tekijä: Karmaker, Swastika
Julkaistu: (2024)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
Tekijä: Mostofa, Golam
Julkaistu: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
Tekijä: Zaman, Rubaiyat
Julkaistu: (2024)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
Tekijä: Tasneem, Sadia
Julkaistu: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
Tekijä: Rahman, Quazi Ashikur, et al.
Julkaistu: (2022)

Role of circular RNA in neurological disease
Tekijä: Salsabil, Labiba
Julkaistu: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
Tekijä: Afreen, Nuraia
Julkaistu: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Tekijä: Haque, Mushfiqul
Julkaistu: (2019)

An overview on Covid-19 and invention of its treatment by drugs
Tekijä: Nawer, Anika
Julkaistu: (2022)

A review on adult neurogenesis in Alzheimer’s disease
Tekijä: Akter, Moriam
Julkaistu: (2022)

Biologics and Biosimilars as Treatment Options for Psoriasis
Tekijä: Moya, Amena Khatun
Julkaistu: (2023)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
Tekijä: Mahee, Sadique Abdal
Julkaistu: (2024)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
Tekijä: Roy, Aditya, et al.
Julkaistu: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
Tekijä: Dey, Manashi
Julkaistu: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
Tekijä: Bakar, Osama Bin Abu
Julkaistu: (2024)

An ambient assisted living system for Alzheimer’s patients
Tekijä: Abedin, Minhajul, et al.
Julkaistu: (2023)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
Tekijä: Jahan, Nusrat
Julkaistu: (2023)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
Tekijä: Sani, Mehedi Hasan, et al.
Julkaistu: (2022)

Treatment regimens of urinary bladder adenocarcinoma
Tekijä: Tarafder, Ayndrila
Julkaistu: (2024)

An overview of migraine disease with modern options for treatment and future aspects
Tekijä: Arifen, MD.
Julkaistu: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
Tekijä: Mahbub, Riasat, et al.
Julkaistu: (2022)

Different approaches in the treatment of obstructive pulmonary diseases
Tekijä: Kabir, Eva Rahman, et al.
Julkaistu: (2016)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
Tekijä: Afsana, Nourin
Julkaistu: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
Tekijä: Alam, Badrul, et al.
Julkaistu: (2016)

Exploring the potential of organic molecules in the treatment of covid-19
Tekijä: Mondol, Winifred Claire
Julkaistu: (2024)